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Abstract
Severe meningococcal sepsis is still of high morbidity and mortality. Its management may be improved by an experimental
model allowing better understanding of its pathophysiology. We developed an animal model of meningococcal sepsis in
transgenic BALB/c mice expressing human transferrin. We studied experimental meningococcal sepsis in congenic
transgenic BALB/c mice expressing human transferrin by transcriptional profiling using microarray analysis of blood and
brain samples. Genes encoding acute phase proteins, chemokines and cytokines constituted the largest strongly regulated
groups. Dynamic bioluminescence imaging further showed high blood bacterial loads that were further enhanced after a
primary viral infection by influenza A virus. Moreover, IL-1 receptor–associated kinase–3 (IRAK-3) was induced in infected
mice. IRAK-3 is a negative regulator of Toll-dependant signaling and its induction may impair innate immunity and hence
result in an immunocompromised state allowing bacterial survival and systemic spread during sepsis. This new approach
should enable detailed analysis of the pathophysiology of meningococcal sepsis and its relationships with flu infection.
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Introduction
Neisseria meningitidis (Nm) is an exclusively human bacterium that
first adheres to the epithelium of the nasopharynx and may then
be translocated to invade the bloodstream. Bacteria can then cross
the blood brain barrier to invade the subarachnoidal space of the
central nervous system. During these phases of invasive infection,
bacteria interact with different cellular barriers and inflammatory
cells. They also release a large number of bacterial components
such as lipooligosaccharide (LOS) and peptidoglyan that in turn
contribute to the bacteria-host interaction [1,2]. The integral
analysis of bacteria-host interaction is hindered by the few
available relevant animal models due to the restriction of Nm to
human [3]. We have recently used transgenic C57B6/SJLJ mice
expressing the human transferrin (hTf) as an animal model for
invasive meningococcal infections [4]. This model allows the
growth of N. meningitidis as it provides bacteria with the
physiological iron source and should permit a reliable analysis of
host-bacteria interactions. This model permitted the analysis of the
virulence of an emergent meningococcal strain in France and
showed its ability to provoke septicemia in these mice with the
induction of cytokine production [5].
Sepsis (combination of systemic inflammatory response syn-
drome (SIRS) and documented infection) is a leading cause of
morbidity and mortality worldwide. Severe sepsis involves acute
organ dysfunction and its incidence is estimated at 300 per
100,000 population in the United States, France and Germany [6–
8]. We aimed to develop an experimental model that contribute to
improve the management of severe sepsis by testing new emerging
treatments (new antibiotics and immune-modulating therapies)
and by the pathophysiological analysis of invasive meningococcal
infection (a pathognomonic severe sepsis with high mortality rate)
combining phenotypical analysis and profiling of gene transcrip-
tion in infected hosts.
Methods
Bacterial strains
N. meningitidis strain LNP24198, is a clinical isolate of serogroup
C, serotype 2a and subtype P1.7,1 (PorA VR1=7.1 and VR2=1).
It belongs to the clonal complex ST-11 and was described
previously [5]. Bacteria were grown on GCB medium (Difco)
containing the supplements described by Kellog et al [9].
Escherichia coli strain DH5 [10] was used for cloning and plasmid
preparation. Luria-Bertani (LB) was used for culturing E. coli.
When appropriate, ampicillin was used at final concentration of
100 mg/ml and kanamycin was added at final concentration of
50 mg/ml and 100 mg/ml for E. coli and N. meningitidis,
respectively.
Firefly Luciferase expressing gene was amplified from the vector
pSP-luc+NF Fusion (Biolabs) using the T7 and SP6 primers
(Table 1). The amplified fragment was then blunt-ended and and
sublconed into the BamH1 restriction site of the previously
described recombinant plasmid pTE-KM [11]. This site is located
between the meningococcal pilE gene encoding the pilin (the
major subunit of pili) and the aph-39 gene that confers resistance to
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pDG29 and used to transform the strain LNP24198 as previously
described [12] to obtain the luciferase expressing strain NM0804.
Mice and experimental infections
BALB/c mice were in-house bred and were kept in a biosafety
containment facility, in filter-topped cages with sterile litter, water
and food, according to institutional guidelines. Congenic mice
were established in our laboratory by 10 backcrossing of male
C57BL/6/SJL progenitors containing hTf gene [4] and BALB/c
females (Janvier France). At every generation, tail biopsies were
collected only females and DNAs were prepared to detect hTf
gene by PCR as previously described [4]. RT-PCR analysis also
confirmed the expression of the gene after the N3 and the N10
backcrosses.
For intraperitoneal bacterial infection of mice, bacterial inocula,
were adjusted to selected density by dilution in phosphate-buffered
saline (PBS). Viral respiratory infection (using the mouse-adapted
influenza A virus strain, A/Scotland/20/74 (H3N2)) was per-
formed as previously described [4,13]. Individual animals were
used for each time point.
Cytokine immunoassays
At selected time points, sera were collected from infected mice
and stored at 280uc until testing by ELISA (R&D Systems
Europe) for the titration of immunoreactive IL-6, TNF-a and KC,
according to manufacturer’s recommendations.
Imaging of bioluminescence from animals
D-luciferin potassium salt (Caliper Life Sciences), the substrate
of Firefly luciferase, was dissolved in phosphate-buffered saline at a
concentration of 30 mg/ml At the appropriate time of infection,
100 ml (3 mg) of luciferin was given to mice by intraperitoneal
injection. Mice were then anesthetized using a constant flow of
2.5% isoflurane mixed with oxygen, using an XGI-8 anesthesia
induction chamber (Xenogen Corp.). The mice were maintained
for at least 5 min so that there was adequate dissemination of the
injected substrate. Bacterial infection images were acquired using
an IVIS 100 system (Xenogen Corp., Alameda, CA) according to
instructions from the manufacturer. Analysis and acquisition were
performed using Living Image 3.1 software (Xenogen Corp.).
Images were acquired using 5 min of integration time with a
binning of 16. All other parameters were held constant.
Quantifying was performed using the photons per second emitted
by each mouse. When required, quantifying was also performed
by defining regions of interest (skull and organs). An uninfected
mouse in the same conditions of acquisition was used for
subtracting the background. For ex vivo analyses, the mouse was
euthanized for removing the organs that were imaged for 10 min
after the addition of the substrate.
Microarray experiments
Animals for RNA preparation (uninfected mice and 6 h-
infected mice) were anesthetized by intraperitoneal injection of
300 mg/kg sodium pentobarbital were exsanguinated by intra-
cardiac puncture and blood was washed out from blood vessels by
intracrdiac injection of 6 ml of phosphate-buffered saline. Brain
was then removed and homogenized. Blood and brain samples
were used to prepare total RNA using Qiagen Kits (RNeasy
protect animal blood kit for blood samples and RNeasy lipid tissue
mini kit for brain samples). RNAs were quantified and 1.5 mg were
used for each experimental condition. We sponsored Beckman
Coulter Genomics (Morrisville, NC, USA) to perform the gene
expression profiling using the Agilent.
Mouse Whole Genome 4644 k Microarrays. Target labeling,
hybridization, washing, scanning and data extraction were lead
using established procedures for the analysis of Eukaryotic RNA
by Agilent Technologies (www.agilent.com). Each condition
(infected and uninfected blood and brain samples) was tested at
last by two different and independent experiments (biological
replicates). Raw microarray data were analyzed using Z Score
transformation [14]. For each spot the median pixel intensity for
the local background of each spot was subtracted from the median
pixel intensity of each spot. Background subtracted pixel intensities
for the infected sample were divided by those for the reference
channel (uninfected sample). The resulting ratios were log
transformed and normalized to the mean of log ratio of all spots
and then expressed as unit of standard deviation (SD) of the SD of
log ratio of all spots to obtain the Z score of each spot.
Differentially expressed transcripts (DET) were then defined as
those that have a log ratio equal, higher or lower than 2 standard
deviations above/below the mean (i.e. Z score of at least 2 for
unregulated transcripts and Z score lower or equal 22 for
downregulated transcripts). The microarray processed data (blood
Table 1. Primers used for RT-PCR analysis.
Mouse genes Forward 59 -3 9 Revers 59 -3 9 cDNA Reference
Crp 59-GGTCATGAAGACATGTTTAAAA-39 59-CCAAAGACTGCTTTGCATCA-39 460 bp This work
Saa3 59-ACAGCCAAAGATGGGTCCAGTTCA-39 59-ATCGCTGATGACTTTAGCAGCCCA-39 185 bp MGI3822749
Irg1 59-ACGGCTTGAAAGTGAACCAC-39 59-GAGGGTGGAATCACTTTGGT-39 439 bp This work
Lcn2 59-GTTCACTCTGGGAAATATGC-39 59-CAGGGGACAGCTCCTTGGTTCTTC-39 167 bp This work
IL-6 59-TTCCTCTCTGCAAGAGACT-39 59-TGTATCTCTCTGAAGGACT-39 452 bp MGI507
Cxcl1 59-GCTGGGATTCACCTCAAGAA-39 59-TGGGGACACCTTTTAGCATC-39 169 bp This work
IL-1b 59-GGCTGCTTCCAAACCTTTGA-39 59-GAAGACACGGATTCCATGGT-39 710 bp MGI2662453
Casp4 59-TGGGAACTCTGGAGAAATG-39 59-AATGAAGTCCTTCTCCACG-39 122 bp MGI2668232
Sele 59-TCTGGACCTTTCCAAAATGG-39 59-CAAGCTAAAGCCCTCATTGC-39 249 bp This work
Selp 59-TCCTGCTACCCAGGCTTCTA-39 59-ATCCCAGAAGCCAAACATTG-39 197 bp This work
Irak3 59- CGGAAAGTCTTCCCTGTCTG-39 59-ACCTCCATGATCACGATTCC-39 192 This work
Hprt 59-AAGCAGTACAGCCCCAAAAT-39 59-CATAGTGCAAATCAAAAGTC-39 392 bp [34]
doi:10.1371/journal.pone.0022210.t001
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http://www.ebi.ac.uk/arrayexpress/).
The DETs that were identified were further subjected to Gene
Ontology (GO) enrichment analysis to identify gene ontology
biological process categories that are over-represented in the set of
DETs in blood and brain samples. Gene ontology analysis was
performed using the Version 2.0 (Released August 15) 2003 of the
Expression Analysis Systematic Explorer (EASE) available on line
(http://david.abcc.ncifcrf.gov/) with Database for Annotation,
Visualization, and Integrated Discovery (DAVID) defined default
values [15]. This analysis clusters genes into biological categories
and calculates the probability of over- and under-representation of
clustered genes within a particular group, compared with the
master list by use of Fisher’s exact test. The expression of several
DETs were also cofrimred by reverse transcriptase (RT)-PCR
assays. Reverse transcription of RNA from blood or brain of
infected and unifected mice were first performed by random
priming using random hexanucleotides then PCR was performed
on cDNA using primers correspondig to the following genes Crp,
Saa3, Irg1, Lcn2 , Il-6, Cxcl1, Il-1b, Casp4, Sele, Selp, Irak3 and
Hprt that used as a control (see Tables 1 ad 2 for details).
Statistical analysis
Data are expressed as the mean 6 SD of triplicate samples, and
the reproducibility was confirmed at least in three separate
experiments. Statistical analysis were performed using student t
test (two-way Annova) test, and considered significant if P,0.05.
Ethics Statement
This study was carried out in strict accordance with the
European Union Directive 2010/63/EU (and its revision 86/609/
EEC) on the protection of animals used for scientific purposes.
Our laboratory has the administrative authorization for animal
experimentation (Permit Number 75-1554) and the protocol was
Table 2. Major groups of upregulated genes in blood and brain of infected mice.
Gene names/products Gene symbol Keywords Accesion N6 Site fold change** Z score
C-reactive protein* Crp Acute phase proteins NM_007768 Brain 1.3 3.1
Calcitonin A Calca NM_007587 Brain 1.9 4.7
Calcitonin receptor like Calcrl NM_007588 Blood 0.3 2
Mannose binding lectin (A) Mbl1 NM_010775 Brain 1.7 4.2
Serum amyloid A1 Saa1 NM_009117 Brain 2.4 5.9
Serum amyloid A3* Saa3 NM_011315 Brain 3.3 8.2
Immunoresponsive gene 1* irg1 AK152177 Brain 2.1 5.1
Lipocalin 2* Lcn2 NM_008491 Brain 1.5 3.5
Peptidoglycan recognition protein2 Pglyrp2 Innate immunity NM_021319 Brain 1.7 4.1
Peptidoglycan recognition protein3 Pglyrp3 NM_207247 Brain 1.1 2.5
Toll-like receptor 4 Tlr4 AK014533 Brain 1.0 2.3
IL-1 receptor–associated kinase–3* Irak3 NM_028679 Brain 1.3 3.1
interleukin-1 beta* Il1b Immune response NM_008361 Brain 1.3 3
interleukin-6* Il6 NM_031168 Blood, Brain 2.2 4, 5.3
interleukin-9 Il9 NM_008373 Brain 1.1 2.5
interleukin-19 Il19 NM_001009940 Brain 2.0 4.8
interleukin-23 Il23 NM_031252 Brain 1.1 2.4
Chemokine Cxcl1 (KC)* Cxcl1 NM_008176 Blood, Brain 2.6 6.4
Chemokine Cxcl2 Cxcl2 NM_009140 Blood, Brain 2.6 6.3
Defensin beta 1 Defb1 NM_007843 Brain 1.3 3.1
Defensin beta 6 Defb6 NM_054074 Brain 1.8 4.4
Defensin beta 7 Defb7 NM_139220 Brain 1.6 3.8
CD80 co-stimulatory molecule) Cd80 NM_009855 Brain 1.6 3.8
Endothelial cells selectin* Sele Cell adhesion NM_011345 Brain 2.4 5.8
Platelet selectin* Selp NM_011347 Brain 2.3 5.6
Claudin 4 Cldn4 NM_009903 Brain 1.0 2.3
Claudin 7 Cldn7 NM_016887 Brain 1.0 2.3
Claudin 17 Cldn17 NM_181490 Brain 1.4 3.4
Claudin 18 Cldn18 NM_019815 Brain 2.2 5.3
Cadherin 2 Cdh2 AK084821 Brain 1.3 3.2
Intercellular adhesion molecule 1 Icam1 NM_010493 Brain 1.0 2.3
Caspase 4* Casp4 Apoptosis NM_007609 Brain 1.1 2.5
*Genes that are also analyzed by RT-PCR.
**Log10 of the ratio of intensity of infected/non infected mice after correction for the background.
doi:10.1371/journal.pone.0022210.t002
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the Regional Committee of Ethics of Animal Experiments of Paris
region (Permit Number: 99-174). All surgery was performed under
sodium pentobarbital anesthesia, and all efforts were made to
minimize suffering.
Results
Establishment of congenic mice expressing human
transferrin
We established a congenic mice expressing hTf gene by
performing 10 backcrosses starting by transgenic male C57BL/
6/SJL [4] mice with BALB/c females. After each backcross,
experimental infection was also performed by intraperitoneal
injection of 5*10
6 CFU of the wild type strain LNP24198.
Significant higher bacterial counts in blood and other organs
were always observed in congenic transgenic mice compared to
their littermate wild-type mice (Fig. 1). The bacterial dose of
5*10
6 CFU of the wild type strain LNP24198 was sublethal for
wild-type mice that recovered after 24 h, whereas 17% mortality
of infected congenic transgenic mice were scored after the same
period of the bacterial challenge (Fig. 1 and Fig. 2). These data
suggest a more severe systemic infection in congenic transgenic
mice that can also be mirrored by the peripheral white blood cell
(WBC) counts after 6 h of bacterial challenge. Slight but not
significant changes were observed in infected wild type compared
to uninfected wild type. Lymphocytes decreased while both
polymorphonuclear leukocytes and monocytes slightly increased
in wild type infected mice after six hours of infections (Table 3).
However, total WBC significantly decreased in infected congenic
transgenic mice. This decrease was mainly observed for lympho-
cytes and monocytes that significantly decreased in infected
congenic transgenic mice compared to uninfected congenic
transgenic mice (Table 3).
The highest levels of proinflammatory cytokines (IL-6, TNF-a
and the murine IL-8 homologue KC) in blood and brain of the
infected mice were observed after 6 h of infection. These levels
were significantly higher in infected congenic transgenic mice than
that in infected wild type mice. IL-6 and KC were detected in the
brain fraction only in infected congenic transgenic mice after 6 h
of infection (Table 4). These data correlate with the results from
bacterial counts in blood and brain as well as the blood cell
formulae. Our data clearly indicate a combination of meningo-
coccal infection in mice with systemic inflammatory response. The
highest biological effects of the experimental infection are observed
at 6 h post infection and were significantly more pronounced in
congenic transgenic mice expressing human transferrin.
Systemic spread of meningococcal infection in mice
Dynamic bioluminescence imaging approach showed that
immediately after the injection of the bacterial suspension, bacteria
were mainly present in the peritoneal cavity and start to spread
through bloodstream as confirmed by the detection of biolumines-
cence signal in blood samples. At this early stage of infection, both
Figure 1. Blood and brain bacterial counts after intraperitoneal
challenge. Congenic mice (wild-type, human transferrin expressing
transgenic mice with or without IAV infection) were challenged by
intraperitoneal injection of 5*10
6 CFU of the N. meningitidis serogroup
C strain LNP24198. At each indicated time point, mice were
anaesthetized, blood samples were withdrawn and then perfusion
was performed for each mouse to wash out blood using phosphate
saline buffer. Brains were then extracted. Blood and brain samples were
plated to determine the bacterial counts in each fraction. Data
represent the means 6 SD from 5 independent experiments of groups
of five mice per time point in each experiment.
doi:10.1371/journal.pone.0022210.g001
Figure 2. Survival curves of congenic transgenic mice expressing the human transferrin. Two groups of 7 mice were infected by influenza
A virus (IAV) by intranasal inhalation. One group of 7 mice inhaled the same volume of phosphate saline buffer. At day 7 of the viral intranasal
infection all the mice from the three groups were infected by intraperitoneal injection of 5*106 CFU of the strain 24198. The mice were observed
during the whole period up to 10 days after the bacterial secondary challenge. The deaths were scored in each group and the data were expressed as
a percentage of survival.
doi:10.1371/journal.pone.0022210.g002
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bioluminescence (Fig. 3A and 3C). In wild type mice, bacteria
remained mainly in the peritoneal cavity 6 h later with no
detectable distal localization of the bioluminescence. At the
opposite, bioluminescence was detectable in distal anatomic sites
with pronounced signals in the skull (Fig. 3A). When the substrate of
firefly luciferase was injected directly into the lateral ventricle after
6 h of bacterial intraperitoneal challenge, only congenic transgenic
mice showed signal but not wild type mice (Fig. 3B). This signal is
most likely due to the presence of viable bacteria in the brain that
can be associated to the endothelial cells of the brain blood vessels
and/or in the cerebrospinal fluid in subarachnoidal space.
Moreover, bioluminescent signal was significantly higher in
congenic transgenic mice compared to the wild type mice as
indicated by the total number of photons detected per second
(Fig. 3C). After 24 h of infection, no emitted photons were detected
(Fig. 3A). These data are in accordance with those obtained from
bacterial counts in blood and brain (Fig. 1).
Host gene expression during experimental infection
We used Agilent gene expression microarray (Whole Mouse
Genome (4644 K) and compared gene expression in infected
versus non infected congenic transgenic mice. RNAs were prepared
from blood and brain after extensive washing to eliminate
circulating blood from vessels. Fold changes were computed and
comparison of expression (infected versus uninfected samples) was
performed using Z score transformation [14]. Genes that have a Z
score exceeding 2 standard deviations above or below the mean
represent the most highly or the least expressed genes, respectively.
The numbers of differentially expressed transcripts (DET) in the
blood ofinfected mice were 977 and 303 genes that were detected to
be upregulated or downregulated, respectively. These numbers
were respectively 2364 and 284 in the brain samples of infected
mice that include central nervous system cells and cells of walls of
blood vessels (mainly endothelial cells).
The gene ontology (GO) analysis of the data allowed clustering
of the DETs. Relevant GO are indicated in (Table 5) and
corresponded to clusters with an enrichment score .1 and a P
value#0.05. GO data showed that most of the DETs were related
to genes involved in innate immune response to sepsis. In
particular, genes involved in acute phase and acute inflammatory
responses were upregulated as well as those of the oxygen and
reactive oxygen species metabolic process. Downregulated DETs
in the blood sample also belonged to innate immune response such
as the complement component factor H (Cfh NM_009888 of the
GO:0045087,innate immune response). Factor H is a negative
regulator of the alternative pathway of complement. While other
positive regulator of the alternative pathway were upregulated
such as the complement factor D (Cfd, NM_013459 of the
GO:0006954,inflammatory response). Several DETs such as
those involved in acute phase inflammation (Crp, lipocalin2, irg1,
serum amyloid 3), cytokines and chemokines expression (IL-6 IL1-
ß and Cxcl1), apoptosis (Caspase 4) and cell adhesion molecules
selectins E and P were confirmed to be upregulated by RT-PCR
(Table 2, Fig. 4). The induction of these genes was not due to the
presence of the hTf gene in transgenic mice as non infected wild
type and transgenic mice showed the similar signal by RT-PCR
(Fig. 4). The DETs were observed in both types of mice although
the induction was stronger in transgenic mice such as Crp and IL-
6 in the brain fraction (Fig. 4). This higher induction in infected
transgenic mice compared to the wild type mice was also observed
in cytokines assays in blood and brain fractions (Table 4). It is of
Table 3. Cell blood formulae in mice.
Uninfected mice Infected wild type mice Infected hTf congenic transgenic mice
Polymorphonuclear cells 8906197 15306574 6106290
Lymphocytes 466061414 250061152 10806210*
Monocytes 250690 3306150 20640*
Total WBC 580061591 436061786 17106410*
Figures indicate the mean of 6 mice 6 standard deviation.
*Significant differences between infected and uninfected mice, P,0.05.
doi:10.1371/journal.pone.0022210.t003
Table 4. Levels of cytokines in blood of infected mice.
wild type mice hTf transgenic mice
2h 6h 2 4h 2h 6h 2 4h
Blood
TNF-a 11916786 ND ND 7136691 564265657* ND
IL-6 21746950 2286322 ND 11716768 3124967905* ND
KC 1097565631 2589689 ND 787368178 6717663265* ND
Brain
TNF-a ND ND ND ND ND ND
IL-6 ND ND ND ND ND ND
KC ND 7536412 ND ND 19686424* 13618
The tested cytokines were not detectable in uninfected mice. Figures indicate the mean of 6 mice 6 standard deviation and (%).
*Significant differences between wild type and transgenic mice, P,0.05. ND: non detected.
doi:10.1371/journal.pone.0022210.t004
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is also induced in the brain fraction (Table 2 and Fig. 4).
Influenza A virus and meningococcal sepsis
We have previously reported an experimental model of sequential
IAV-Nm infection in BALB/c mice [13]. This model takes
advantage from the observation of the spatiotemporal association
between flu epidemics and meningococcal infectious [16,17]. We
therefore tested whether a prior viral infection with influenza A virus
(IAV) can also enhance systemic meningococcal infection and
increase the level of bacteraemia to allow more effective bacterial
localization in the brain of congenic transgenic mice.
Higher bacterial counts in blood and brain were observed after
6 h and 24 h of infection in IAV-Nm infected congenic transgenic
mice than that detected in Nm-infected congenic transgenic mice
(Fig. 1). Moreover, higher mortality was also observed in IAV-Nm
infected congenic transgenic mice with 83% of death after 24 h
and 100% of mortality after three days of the bacterial infection.
Mortality level was 17% among Nm-infected congenic transgenic
mice after 24 h of bacterial infection and all the other surviving
mice recovered from the bacterial infection (Fig. 2). Dynamic
imaging showed significant higher signal of bioluminescence in
congenic transgenic mice that were first infected by IAV at J-7
before the bacterial intraperitoneal challenge. It is noteworthy that
the emission of photons continued to increase at 24 hours of
infection with even more pronounced signal in the skull
(Fig. 3D).Upon dissection of infected mice, signal were detected
in blood, spleen, liver ad brain (Fig. 5). These data further support
Figure 3. Dissemination of N. meningitidis in BALB/c congenic mice that were infected by intraperitoneal injection of 5*10
6 CFU of N.
meningitidis (Nm) strain NM0804 expressing the luciferase. Mice were then analyzed for bioluminescence at the indicated times. Images
depict photographs overlaid with colour representations of luminescence intensity, measured in photons/second and indicated on the scales, where
red is most intense and blue is least intense. (Top row) (A) Ventral views of a three transgenic mice expressing human transferrin (hTf/+) and two wild
type mice (+/+) at the indicated times. The framed region of the first transgenic mice is shown below for more details of the bioluminescence
imaging in the skull. (B) Dorsal view of the skull of one transgenic mouse expressing human transferrin and one wild type mouse. The substrate of
firefly luciferase was injected directly into the lateral ventricle after 6 h of bacterial intraperitoneal challenge. (C) The luminescence of the hTf/+ and
(+/+) mice from A and D was quantified and expressed as means 6 SD from each category at the indicated times by defining specific representative
region of interest encompassing the entire animal.(D) Ventral views of a three transgenic mice expressing human transferrin (hTf/+) and two wild
type mice (+/+) at the indicated times. Mice were first infected by influenza A virus (IAV) by intranasal inhalation. Mice were then infected after 7 days
by N. meningitidis (Nm) strain NM0804 by intraperitoneal injection. The framed region of the first transgenic mice is shown below for more details of
the bioluminescence imaging in the skull.
doi:10.1371/journal.pone.0022210.g003
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secondary meningococcal with the primary intranasal IAV
infection that enhances the systemic meningococcal infection by
intraperitoneal route. Recent microarray data showed that
enriched GO terms in response to IAV infection contained
biological process of innate immune response such as
GO:0045087 [18]. This GO is also enriched in our microarray
analysis (Table 5). It is noteworthy that this GO contains the factor
H binding gene that may show the same regulation as the human
gene as Nm binds specifically human factor H [19,20] Indeed, the
administration of human fH to infant rats challenged increased
significantly the bacterial load in blood [21].
Discussion
Meningococcal components (pathogen associated molecular
patterns, PAMPs) such as the LOS and peptidoglycan are released
and are responsible for the induction of systemic inflammatory
Table 5. Major gene ontology GO groups.
GO Term Number of DETs
% of DETs in the
corresponding Term
Upregulated blood
GO:0006954,inflammatory response 11 3
GO:0007155,cell adhesion 43 5.4
GO:0008092,cytoskeletal protein binding 34 4.3
GO:0007267,cell-cell signaling 29 3.7
GO:0044421,extracellular region part 50 6.3
GO:0005125,cytokine activity 17 2.1
GO:0045893,positive regulation of transcription. DNA-dependent 24 3.0
Upregulated brain
GO:0044421,extracellular region part 113 6.9
GO:0006952,defense response 70 4.3
GO:0005125,cytokine activity 40 2.4
GO:0007186,G-protein coupled receptor protein signaling pathway 162 9.9
GO:0009617,response to bacterium 27 1.7
GO:0004175,endopeptidase activity 53 3.2
GO:0004222,metalloendopeptidase activity 19 1.2
GO:0006953,acute-phase response 10 0.6
GO:0019882,antigen processing and presentation 13 0.8
GO:0002064,epithelial cell development 6 0.4
GO:0001819,positive regulation of cytokine production 12 0.7
GO:0050727,regulation of inflammatory response 11 0.7
GO:0016337,cell-cell adhesion 25 1.5
GO:0045944,positive regulation of transcription from RNA polymerase II promoter 39 2.4
GO:0033028,myeloid cell apoptosis 3 0.2
GO:0030593,neutrophil chemotaxis 5 0.3
Downregulated blood
GO:0045087,innate immune response 6 2.2
GO:0005764,lysosome 93 . 2
GO:0004672,protein kinase activity 18 6.5
GO:0001846,opsonin binding 31 . 1
GO:0050764,regulation of phagocytosis 4 1.4
GO:0030001,metal ion transport 14 5.1
Downregulated brain
GO:0016021,integral to membrane 73 34.1
GO:0003700,transcription factor activity 19 8.9
GO:0007186,G-protein coupled receptor protein signaling pathway 36 16.8
GO:0007166,cell surface receptor linked signal transduction 41 19.2
GO:0048538,thymus development 4 1.9
GO:0006955,immune response 10 4.7
GO:0009408,response to heat 31 . 4
doi:10.1371/journal.pone.0022210.t005
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sponding pattern recognition molecules such as Toll-like receptors
(TLRs), peptidoglycan recognition proteins (PGRP) and Nod
family (Nucleotide-binding oligomerization domain containing
proteins). Significant induction was observed in the brain samples
for TLR4, IRG1, PGRP2 and PGRP3. These data corroborate
the apparent tropism to the central nervous system as suggested by
the dynamic imaging, the cytokine production and the detection of
viable bacteria in the brain samples. Upon recognition of the
meningococcal PAMPs, signal is transduced through pathways
involving MyD88, IL-1 receptor–associated kinase–1 (IRAK-1)
and IRAK-4. Once IRAK complex is phosphorylated it interacts
with TRAF6 (TNF –a receptor associated factor 6) that leads to
downstream activation of NF-kB and the induction of proin-
flammatory cytokines and chemokines [22,23]. Genes of the signal
transduction pathways were activated in our transcriptomic
profiling analysis of brain samples (Table 5 GO:0007186).
Interestingly, our microarray data also show the induction of
interleukin-1 receptor-associated kinase 3 (IRAK-3 also known as
IRAK-M) in the brain samples. IRAK-3 negatively regulates TLR
signaling [24,25] and may hence impair cell function upon the
presence of bacterial PAMPs. IRAK-3 plays a pivotal role in
innate immunity that may result in an immunocompromised state
during sepsis [26]. After the early proinflammatory response in
sepsis, a subsequent antiinflammatory step is suggested to worsen
sepsis in part due to sepsis-induced leukocyte ‘‘immunoparalysis’’.
Indeed, fatality was higher in patients with sepsis associated with
monocyte deactivation [27]. Moreover, peripheral blood mono-
cytes isolated from septic patients displayed enhanced expression
of IRAK-3, as compared with cells isolated from nonseptic
controls [28]. Our data on the low number of circulating
monocytes and the induction of IRAK-3 are in agreement of this
scheme. The absence of IRAK-3 was shown to lead to better
clearance of Pseudomonas aeruginosa.from the lung and blood in mice
[26].
Figure 4. RT-PCR analysis on agarose gel electrophoresis using total RNA extracted from the blood (A) and brain (B) of congenic
transgenic and wild type mice expressing human transferrin. RT-PCR experiments for the indicated genes were realized using primers
indicated in Table 1. (2) and (+) above the gels indicate uninfected and infected mice respectively. Length markers in bp are shown on the right.
doi:10.1371/journal.pone.0022210.g004
Figure 5. Ex-vivo images of organs from mouse infected by
influenza A virus (IAV) intranasal inhalation and by Nm at day
7 by intraperitoneal injection. Mouse was dissected to determine
which organs were the sources of bioluminescence. The spleen, liver
and brain were hence removed and the mixture containing the
substrate of firefly luciferase was added. Dynamic bioluminescence
imaging from noninfected (A) or infected organs (B) are shown.
doi:10.1371/journal.pone.0022210.g005
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central nervous system may be responsible for pronounced
modification of these cells in infected transgenic mice. KC
chemokine constantly detected in the brain samples (Table 4)
and transcriptomic profiling showed induction of adhesion
molecules such as endothelial cells selectin (SelE) and Intercellular
adhesion molecule ICAM-1 in the brain samples. Other cell-to-cell
adhesion molecules were also induced such as integrins, cadherins
and catenins in the brain samples.
Acute phase markers such CRP and the calcitonin genes family
as well as those belonging to serum amyloid A and lipocalin
families are also induced in the brain samples, suggesting direct
interaction of bacteria and bacterial components with cells in these
samples. Lipocalin 2 (LCN2) was recently reported as an acute
phase protein to be produced at the blood brain barrier by the
choroid plexus epithelial cells and the endothelial cells of blood
vessels [29]. The expression of serum amyloid 3 (ssa3) was
reported to be induced in epithelial cells through TLR4/MyD88/
NF-kB Signaling pathway [30]. Our data show that genes
encoding acute phase proteins, chemokines and cytokines
constituted the largest strongly regulated group.
Induction of apoptosis and/or its modulation is increasingly
reported in pathogenic bacteria [31]. We have recently reported
that meningococcal strains of the clonal complex ST-11, such as
the strain LNP24198 used in the current study, are able to
upregulate TNF-a receptor I (TNFRI) in epithelial cells and to
induce apoptosis through of TNF-a/TNFRI signaling [32]. Our
data confirm this finding as several transcripts corresponding to
the tumor necrosis factor receptor superfamily were induced such
as the member 10b (Tnfrsf10b) involved in TNF-a-related
apoptosis [33].
We presented in this work an extensive approach of
characterization of experimental meningococcal sepsis paving
the way for preclinical research. Detailed analyses of the
functions/roles of differentially expressed genes completed by
kinetics of gene expression should allow better understanding of
the pathophysiology of this sepsis as well as the analysis of new
therapeutic approaches.
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